User:Carlos Vázquez García/TFG
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
<span style="margin:10px;font-size:16px;">Índice de contenidos</span> | <span style="margin:10px;font-size:16px;">Índice de contenidos</span> | ||
| - | <span style="margin-left:20px;">[http://www.example.com 1. Resumen]</span> | + | <span style="margin-left:20px;">[http://www.example.com 1. Resumen / Abstract]</span> |
| + | <span style="margin-left:20px;">[http://www.example.com 2. Palabras clave / Keywords]</span> | ||
| + | <span style="margin-left:20px;">[http://www.example.com 3. Introducción]</span> | ||
| + | <span style="margin-left:20px;">[http://www.example.com 4. Objetivos]</span> | ||
| + | <span style="margin-left:20px;">[http://www.example.com 5. Metodología y Materiales]</span> | ||
| + | <span style="margin-left:30px;">[http://www.example.com 5.1. Metodología]</span> | ||
| + | <span style="margin-left:30px;">[http://www.example.com 5.2. Materiales]</span> | ||
| + | <span style="margin-left:20px;">[http://www.example.com 6. Desarrollo, resultados y discusión]</span> | ||
| + | <span style="margin-left:30px;">[http://www.example.com 6.1. Estudio de las estructuras primaria, secundaria y terciaria de K-RAS]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.1.1. Análisis de la estructura primaria]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.1.2. Análisis de la estructura secundaria]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.1.3. Análisis de la estructura terciaria]</span> | ||
| + | <span style="margin-left:30px;">[http://www.example.com 6.2. Función y Mecanismo de K-RAS. Ligandos y sitios de unión]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.2.1. Mecanismo de activación e inactivación de K-RAS]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.2.2. Bolsillo de la proteína]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.2.3. Guanosín 5'-trifosfato (GTP)]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.2.4. Guanosín 5'-difosfato (GDP)]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.2.5. Catión Magnesio 2+]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.2.6. Nuevos ligandos]</span> | ||
| + | |||
| + | <span style="margin-left:50px;">[http://www.example.com 6.2.6.1. 4-bromobenzotiol]</span> | ||
| + | <span style="margin-left:50px;">[http://www.example.com 6.2.6.2. Benzimidina]</span> | ||
| + | <span style="margin-left:50px;">[http://www.example.com 6.2.6.3. N-{1-[N-(2,4-diclorofenil)glicil]piperidin-4-il}etinilsulfonamida]</span> | ||
| + | |||
| + | |||
| + | <span style="margin-left:30px;">[http://www.example.com 6.3. Mutaciones en K-RAS]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.3.1. Leucemia]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.3.2. Cáncer de pulmón]</span> | ||
| + | <span style="margin-left:40px;">[http://www.example.com 6.3.3. Cáncer gástrico]</span> | ||
| + | |||
| + | <span style="margin-left:20px;">[http://www.example.com 7. Conclusiones]</span> | ||
| + | <span style="margin-left:20px;">[http://www.example.com 8. Bibliografía]</span> | ||
</div> | </div> | ||
|} | |} | ||
